203 related articles for article (PubMed ID: 19351956)
1. HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells.
Urbich C; Rössig L; Kaluza D; Potente M; Boeckel JN; Knau A; Diehl F; Geng JG; Hofmann WK; Zeiher AM; Dimmeler S
Blood; 2009 May; 113(22):5669-79. PubMed ID: 19351956
[TBL] [Abstract][Full Text] [Related]
2. Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors.
Tsou PS; Wren JD; Amin MA; Schiopu E; Fox DA; Khanna D; Sawalha AH
Arthritis Rheumatol; 2016 Dec; 68(12):2975-2985. PubMed ID: 27482699
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway.
Liu X; Zheng N; Shi YN; Yuan J; Li L
J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis.
Ha CH; Wang W; Jhun BS; Wong C; Hausser A; Pfizenmaier K; McKinsey TA; Olson EN; Jin ZG
J Biol Chem; 2008 May; 283(21):14590-9. PubMed ID: 18332134
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of endothelial Slit2/Robo1 signaling by thalidomide restrains angiogenesis by blocking the PI3K/Akt pathway.
Li Y; Fu S; Chen H; Feng Q; Gao Y; Xue H; Ge Z; Fang J; Xiao S
Dig Dis Sci; 2014 Dec; 59(12):2958-66. PubMed ID: 25326112
[TBL] [Abstract][Full Text] [Related]
6. Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.
Kim J; Hwangbo C; Hu X; Kang Y; Papangeli I; Mehrotra D; Park H; Ju H; McLean DL; Comhair SA; Erzurum SC; Chun HJ
Circulation; 2015 Jan; 131(2):190-9. PubMed ID: 25336633
[TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory mechanism of SAHA in acute pancreatitis through HDAC5/SLIT2/Akt/β-catenin axis.
Tong J; Zhou J; Fang M; Wang G; Fu S; Sun B; Lv J
Hum Mol Genet; 2022 Jun; 31(12):2023-2034. PubMed ID: 35022732
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism.
Hrgovic I; Doll M; Pinter A; Kaufmann R; Kippenberger S; Meissner M
Exp Dermatol; 2017 Feb; 26(2):194-201. PubMed ID: 27487811
[TBL] [Abstract][Full Text] [Related]
9. Class I and IIa histone deacetylases have opposite effects on sclerostin gene regulation.
Baertschi S; Baur N; Lueders-Lefevre V; Voshol J; Keller H
J Biol Chem; 2014 Sep; 289(36):24995-5009. PubMed ID: 25012661
[TBL] [Abstract][Full Text] [Related]
10. HDAC4 and HDAC5 form a complex with DREAM that epigenetically down-regulates NCX3 gene and its pharmacological inhibition reduces neuronal stroke damage.
Formisano L; Laudati G; Guida N; Mascolo L; Serani A; Cuomo O; Cantile M; Boscia F; Molinaro P; Anzilotti S; Pizzorusso V; Di Renzo G; Pignataro G; Annunziato L
J Cereb Blood Flow Metab; 2020 Oct; 40(10):2081-2097. PubMed ID: 31696766
[TBL] [Abstract][Full Text] [Related]
11. Converse role of class I and class IIa HDACs in the progression of atrial fibrillation.
Zhang D; Hu X; Li J; Hoogstra-Berends F; Zhuang Q; Esteban MA; de Groot N; Henning RH; Brundel BJJM
J Mol Cell Cardiol; 2018 Dec; 125():39-49. PubMed ID: 30321539
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 5 (HDAC5) regulates neuropathic pain through SRY-related HMG-box 10 (SOX10)-dependent mechanism in mice.
Gu P; Pan Z; Wang XM; Sun L; Tai LW; Cheung CW
Pain; 2018 Mar; 159(3):526-539. PubMed ID: 29447134
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis.
Esser JS; Rahner S; Deckler M; Bode C; Patterson C; Moser M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):358-67. PubMed ID: 25503991
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor Erg regulates expression of histone deacetylase 6 and multiple pathways involved in endothelial cell migration and angiogenesis.
Birdsey GM; Dryden NH; Shah AV; Hannah R; Hall MD; Haskard DO; Parsons M; Mason JC; Zvelebil M; Gottgens B; Ridley AJ; Randi AM
Blood; 2012 Jan; 119(3):894-903. PubMed ID: 22117042
[TBL] [Abstract][Full Text] [Related]
15. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
Huang Y; Tan M; Gosink M; Wang KK; Sun Y
Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors enhance endothelial cell sprouting angiogenesis in vitro.
Jin G; Bausch D; Knightly T; Liu Z; Li Y; Liu B; Lu J; Chong W; Velmahos GC; Alam HB
Surgery; 2011 Sep; 150(3):429-35. PubMed ID: 21878227
[TBL] [Abstract][Full Text] [Related]
18. Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9.
Lenoir O; Flosseau K; Ma FX; Blondeau B; Mai A; Bassel-Duby R; Ravassard P; Olson EN; Haumaitre C; Scharfmann R
Diabetes; 2011 Nov; 60(11):2861-71. PubMed ID: 21953612
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling.
Deroanne CF; Bonjean K; Servotte S; Devy L; Colige A; Clausse N; Blacher S; Verdin E; Foidart JM; Nusgens BV; Castronovo V
Oncogene; 2002 Jan; 21(3):427-36. PubMed ID: 11821955
[TBL] [Abstract][Full Text] [Related]
20. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
